Four-year safety follow-up of the tetravalent dengue vaccine CYD-TDV

被引:6
|
作者
Wilder-Smith, A. [1 ,2 ]
机构
[1] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore
[2] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany
关键词
CYD-TDV; Dengue; Safety follow-up; Tetravalent dengue vaccine; Vaccine;
D O I
10.1016/j.cmi.2018.03.024
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:680 / 681
页数:2
相关论文
共 50 条
  • [21] Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America
    Carpp, Lindsay N.
    Fong, Youyi
    Bonaparte, Matthew
    Moodie, Zoe
    Juraska, Michel
    Huang, Ying
    Price, Brenda
    Zhuang, Yingying
    Sheo, Jason
    Zheng, Lingyi
    Chambonneau, Laurent
    Small, Robert
    Sridhar, Saranya
    DiazGranados, Carlos A.
    Gilbert, Peter B.
    PLOS ONE, 2020, 15 (06):
  • [22] BRIDGING EFFICACY OF THE CYD-TDV TETRAVALENT DENGUE VACCINE FROM CHILDREN/ADOLESCENTS TO ADULTS IN HIGH ENDEMIC COUNTRIES BASED ON NEUTRALIZING ANTIBODY RESPONSE
    Gilbert, Peter B.
    Huang, Ying
    Juraska, Michal
    Moodie, Zoe
    Fong, Youyi
    Luedtke, Alexander
    Zhuang, Yingying
    Shao, Jason
    Carpp, Lindsay N.
    Jackson, Nicholas
    Chambonneau, Laurent
    Bouckenooghe, Alain
    Zambrano, Betzana
    Frago, Carina
    Pallardy, Sophie
    Noriega, Fernando
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 248 - 248
  • [23] Post-authorization safety study: Cohort event monitoring for CYD-TDV dengue vaccine (DNG15)
    Levesque, Linda
    Johannes, Catherine B.
    Lecciones, Julius A.
    Giamberardino, Heloisa
    Marcelon, Lydie
    Cohen, Carine
    Rojas, Andrey
    Bennett, Lee
    Khromava, Alena
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 592 - 593
  • [24] Replication and Excretion of the Live Attenuated Tetravalent Dengue Vaccine CYD-TDV in a Flavivirus-Naive Adult Population: Assessment of Vaccine Viremia and Virus Shedding
    Torresi, Joseph
    Richmond, Peter C.
    Heron, Leon G.
    Qiao, Ming
    Marjason, Joanne
    Starr-Spires, Linda
    van der Vliet, Diane
    Jin, Jing
    Wartel, T. Anh
    Bouckenooghe, Alain
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 (07): : 834 - 841
  • [25] Dissecting Antibodies Induced by a Chimeric Yellow Fever-Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals
    Henein, Sandra
    Swanstrom, Jesica
    Byers, Anthony M.
    Moser, Janice M.
    Shaik, S. Farzana
    Bonaparte, Matthew
    Jackson, Nicholas
    Guy, Bruno
    Baric, Ralph
    de Silva, Aravinda M.
    JOURNAL OF INFECTIOUS DISEASES, 2017, 215 (03): : 351 - 358
  • [26] Refined efficacy estimates of the Sanofi Pasteur dengue vaccine CYD-TDV using machine learning
    I. Dorigatti
    C. A. Donnelly
    D. J. Laydon
    R. Small
    N. Jackson
    L. Coudeville
    N. M. Ferguson
    Nature Communications, 9
  • [27] Refined efficacy estimates of the Sanofi Pasteur dengue vaccine CYD-TDV using machine learning
    Dorigatti, I.
    Donnelly, C. A.
    Laydon, D. J.
    Small, R.
    Jackson, N.
    Coudeville, L.
    Ferguson, N. M.
    NATURE COMMUNICATIONS, 2018, 9
  • [28] DISSECTING ANTIBODY RESPONSE INDUCED BY CHIMERIC YELLOW FEVER-DENGUE, LIVE- ATTENUATED, TETRAVALENT DENGUE VACCINE (CYD-TDV) TO UNDERSTAND VACCINE EFFICACY IN NAIVE AND DENGUE EXPOSED INDIVIDUALS
    Henein, Sandra
    Bonaparte, Matthew
    Baric, Ralph
    Swanstrom, Ar Jesica
    Byers, Tony
    Moser, Janice
    Guy, Bruno
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 424 - 424
  • [29] Consumer Willingness to Pay for Dengue Vaccine (CYD-TDV, Dengvaxia®) in Brazil; Implications for Future Pricing Considerations
    Godoi, Isabella P.
    Santos, Andre S.
    Reis, Edna A.
    Lemos, Livia L. P.
    Brandao, Cristina M. R.
    Alvares, Juliana
    Acurcio, Francisco A.
    Godman, Brian
    Guerra Junior, Augusto A.
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [30] Updated recommendations of the International Dengue Initiative expert group for CYD-TDV vaccine implementation in Latin America
    Torres, J. R.
    Falleiros-Arlant, L. H.
    Gessner, B. D.
    Delrieu, I
    Avila-Aguero, M. L.
    Giambernardino, H. I. G.
    Mascarenas, A.
    Brea, J.
    Torres, C. N.
    Castellanos-Martinez, J. M.
    VACCINE, 2019, 37 (43) : 6291 - 6298